Difficulties in Irritable Bowel Syndrome: Disease Definition, Epidemiology, Pain Management and Treatment

Document Type : Review Article


Department of Gastroenterology, Nuffield Hospital, Leicester, LE5 5HY UK


The diagnosis and definition of irritable bowel syndrome is problematic. However, its existence as a disease entity has been recognised for at least a thousand years with both Rhazes and ibn Sina discussing the constellation of symptoms which make up thye syndrome. In recent times attention has focused on which symptoms and their duration are critical to the diagnosis. This work has been encapsulated in the reports of the Rome Foundation. The difficulties in disease definition have led to wide variations between reports on the condition’s prevalence in both within and between countries. Nevertheless, it is clear that irritable bowel syndrome is common across all societies. It is consequently of concern that allopathic medications are of limited benefit, particularly in the management of pain, and this has generated a growing interest in traditional therapies as well as hypnotherapy and acupuncture. This review touches on these issues and will hopefully stimulate further research.


1. Mitra D, Davis KL & Baran RW
(2011) All-cause health care charges
among managed care patients with
constipation and co-morbid irritable
bowel syndrome. Postgraduate
Medicine 123: pp 122 – 132
2. Powell R (1820) On certain painful
affections of the intestinal canal.
Medical Transactions of the Royal
College of Physicians 6: pp 106 – 107
3. Naseri M, Babaeian M, Ghaffari F,
Kamalinejad M, Feizi A, Mazaheri
M et al (2016) Bloating: Avicenna’s
perspective and modern medicine
Journal of Evidence-Based
Complementary & Alternative
Medicine 121(2): pp 154-159
4. Mosleh G, Mohagheghzadeh A,
Hamedi A, Salehi M & Hosseini SMK
(2013) Irritable Bowel Syndrome
Pathophysiology According to
Traditional Iranian Medicine https://
ibimapublishing.com /ar ticles/
(Accessed 14/2/2022)
5. Peters GA & Bargen JA (1944)
The irritable bowel syndrome.
Gastroenterology 3: pp 399 -402.
6. Brown PW (1947) The irritable bowel
syndrome Journal of the Kansas
Medical Society 48(7): pp 309 – 312
7. Chumpitazi BP & Shulman RJ (2016)
Underlying molecular and cellular
mechanisms inn childhood irritable
bowel syndrome. Molecular and
Cellular Pediatrics 3(1): p 11
8. Quigley EMM (2018) The Gut-Brain
Axis and the Microbiome: Clues to
Pathophysiology and Opportunities
for Novel Management Strategies
in Irritable Bowel Syndrome (IBS)
Journal of Clinical Medicine 7: 6;
9. El-Sahy M, Hatlebakk JG, Gilja
OH, Ktistoffersen AB & Hausken T
(2020) Efficacy of faecal microbiota
transplantation for patients with
irritable bowel syndrome in
a randomised, double=blind,
placebo=controlled study. Gut 69:
pp. 859 - 867
10. Manning AP, Thompson WG, Heaton
KW & Morris AF (1978) Towards
positive diagnosis of the irritable
bowel. British Medical Journal
2(6138): pp 653 – 654
11. Drossman DA (2016) Rome IV.
Functional Gastrointestinal
Disorders. Disorders of Gut-Brain
Interaction. 4th E dition R ome
Foundation Raleigh
12. Mujagic Z., Keszthelyi D, Aziz
Q, Reinsisch W, Quetglas EG, De
Leonardis F et al (2015) Systematic
review: instruments to assess
abdominal pain in irritable bowel
syndrome. Alimentary Pharmacology
& Therapeutics 42: pp 1064 – 1081
13. Simren M, Mansson A, Langkilde
AM, Svedlund J, Abrahamsson H,
Bengtsson U et al (2001) Digestion
63 (2): pp 108 – 115
14. Patel A, Hasak S, Cassell B, Cioba
MA, Vivio EE, Kumar M et al
(2016) Effects of disturbed sleep
on gastrointestinal and somatic
pain symptoms in IBS. Alimentary
Pharmacology & Therapeutics 44(3):
pp 246 – 258
15. Buchanan DT, Cain K, Heitkemper M,
Burr R, Vitiello MV, Zia J et al (2014)
Sleep measures predict next-day
symptoms in women with irritable
bowel syndrome. Journal of Clinical
Sleep Medicine 10(9): pp 1003 – 1009
16. Hong-Yan Q, Chung-Wah C,
Xu-Dong & Bhian ZX (2014) Impact
of psychological stress on irritable
bowel syndrome. World Journal of
Gastroenterology 20(39): pp 14126
– 14131
17. Fond G, Loundou A, Hamdani N,
Boukouaci W, Dargel A, Oliveira J
et al (2014) A nxiety and depression
comorbidities in irritable bowel
syndrome(IBS): a systematic
review and meta-analysis. European
Archives of Psychiatry & Clinical
Neuroscience 264(8): pp 651 – 660
18. Hillila MT & Farkkila MA (2004)
Prevalence of irritable bowel
syndrome according to different
diagnostic criteria in a non-selected
adult population. Alimentary
Pharmacology & Therapeutics 20(3):
pp 339 - 345
19. Anand AC, Saiprasad GS &
Bhalwar R (1998) A search for
unhappy abdomen: prevalence of
irritable bowel syndrome in general
population. Medical Journal, Armed
Forces India 54(2): pp 123 - 127
20. Waehrens R, Ohlsson H, Sundquist
J, Sundquist K & Zoller B (2013)
Low prevalence of irritable bowel
syndrome in primary health care in
four Swedish counties. Scandinavian
Journal of Primary Health Care
31(3): pp 132 – 137
21. Zuckerman MJ, Schmulson MJ,
Bashashati M, Jia Y, Dwivedi A,
Ortiz M et al (2018) Irritable bowel
syndrome on the US Mexico Border:
A survey in an indigent population
using Rome III criteria. Journal of
Clinical Gastroenterology 52(7): pp
622 – 627
22. Lovell RM & Ford AC (2012)
Effect of gender on prevalence of
irritable bowel syndrome in the
community: systematic review and
meta-analysis. American Journal
of Gastroenterology 107(7): pp 991
– 1000
23. Pan C-H, Chang C-C, Su C-T &
Tsai P-S (2016) Trends in irritable
bowel syndrome incidence among
Taiwanese adults during 2003 –
2013: a population based study of sex
anad age differences. PLoS 11(11):
e0166922. doi: 10.1371/journal.
24. Talley NJ, Zinsmeister AR &
Melton LJ (1995) Irritable bowel
syndrome in a community: symptom
subgroups, risk factors, and health
care utilization. American Journal
of Epidemiology 142(1): pp 76 - 83
25. Krogsgaard LR, Engsbro AL,
Jones MP & Bytzer P (2017) The
epidemiology of irritable bowel
syndrome: Symptom development
over a 3-year period in Denmark. A
prospective, population-based cohort.
Neurogastroenterology & Motility
29(4): doi: 10.1111/nmo.12986. Epub
2016 Nov 14.
26. Schauer B, Grabe HJ, Itterman T,
Lerch MM, Weiss FU, Mőnnikes H
et al (2019) Irritable bowel syndrome,
mental health, and quality of life:
Data from a population-based
survey in Germany (SHIP-Trend-0)
Neurogastroenterology & Motility
31(3): e13511. doi: 10.1111/nmo.13511
27. Dai N, Cong Y & Yuan H (2008)
Prevalence of irritable bowel
syndrome among undergraduates in
Southeast China. Digestive and Liver
Disease 40(6): pp 418 - 424
28. Xiong LS, Chen MH, Chen HX,
Xu AG, Wang WA et al (2004) A
population-based study of irritable
bowel syndrome in South China:
stratified randomized study by cluster
sampling. Alimentary Pharmacology
& Therapeutics 19(11): p p 1 217
– 1224
29. Zhang L, Duan L, Liu Y, Leng
Y, Zhang H, Liu Z et al (2014) A
meta-analysis of the prevalence of
irritable bowel syndrome in Chinese
community. Zhonghua nei ke za zhi
53(12): pp 969 – 975
30. Satake R, Sugawara N, Sato K,
Takahashi I, Nakaji S, Yasui-
Furukori N et al (2015) Prevalence
and predictive factors of irritable
bowel syndrome in a communitydwelling
population in Japan. Internal
Medicine 54(24): pp 3105 – 3112
31. Yamamoto R, Kaneita Y, Osaki Y, Kanda H, Suzuki K, Higuchi S et
al (2015) Irritable bowel syndrome
among Japanese adolescents: a
nationally representative survey.
Journal of Gastroenterology &
Hepatology 30(9): pp 1354 – 1360
32. Yun CH, Lee SK, Kim H, Park
HK, Lee SH, Kim SJ et al (2012)
Association between irritable bowel
syndrome and restless legs in the
general population. Journal of Sleep
Research 21(5): pp 569 – 576
33. Zuckerman MJ, Nguyen G, Ho H,
Nguyen L & Gregory GG (2006) A
survey of irritable bowel syndrome
in Vietnam using the Rome criteria.
Digestive Diseases & Sciences 51(5):
pp 946- 951
34. K ho sh k r o o d -Ma n s o or i B,
Pourhoseingholi MA, Safaee A,
Moghimi-Dehkordi B, Sedigh-
Tonekaboni B, Pourhoseingholi A et
al (2009) Irritable bowel syndrome:
a population based study. Journal of
Gastrointestinal and Liver Diseases
18(4): pp 413 – 418
35. Massarrat S, Saberi-Firoozi, A,
Himmelmann GW, Hitzges M &
Keshavarz H (1995) Peptic ulcer
disease, irritable bowel syndrome
and constipation in two populations
in Iran European Journal of
Gastroenterology and Hepatology
7: pp 427 - 433
36. Hoseini-Asl MK & Amra B (2003)
Prevalence of irritable bowel
syndrome in Shahrekord, Iran Indian
Journal of Gastroenterology 22: pp
215 – 216
37. Khademolhosseini F, Mehrabani D,
Nejabat M, Beheshti M, Heydari
ST, Mirahmadizadeh A et al (2011)
Irritable bowel syndrome in adults
over 25 years in Shiraz, southern Iran:
prevalence and associated factors
Journal of Research in Medical
Sciences 16: pp 200–206
38. Okeke EN, Ladep NG, Adah S,
Bupwatda PW, Agaba EI & Malu AO
(2009) Prevalence of irritable bowel
syndrome: a community survey in an
African population. Annals of African
Medicine 8(3): pp 170 -180
39. Madrid-Silva AM, Defilippi-Caffri C,
Landskron-Ramos G, Olquín-Herrera
F, Reyes-Ponce A, Castro-Lara A et
al (2013) The prevalence of irritable
bowel syndrome in a population of
shopping mall visitors in Santiago de
Chile. Revista de Gastroenterologia
de Mexico 78(4): pp 203 – 210
40. Álvarez DFG, Vargas JGM, Medina
LMAR, Oviedo SCM, López PAC
& Jaimes GER (2009) Prevalence
of irritable bowel syndrome and
associated factors according to
Rome lll diagnostic criteria in a
general population in Colombia.
Gastroenterology & Hepatology
32(6): pp 395 – 400
41. Ruepert L, Quartero AO, de Wit NJ, van
der Heijden GJ, Rubin G & Muris JW
(2011) Bulking agents, antispasmodics
and antidepressants for the treatment
of irritable bowel syndrome.
Cochrane Database Systematic
Reviews Aug 10;(8):CD003460. doi:
42. Rees WD, Evans BK & Rhodes
J (1979) Treating irritable bowel
syndrome with peppermint oil British
Medical Journal 2(194): pp 835 – 836
43. Mosaffa-Jahromi M, Lankarani KB,
Pasalar M, Ashfarypuor S & Tamaddon
A (2016) Efficacy and safety of enteric
coated capsules of anise oil to treat
irritable bowel syndrome. Journal of
ethnopharmacology 194: pp 937 - 946
44. Whorwell PJ, Prior A & Faragher
EB (1984) Controlled trial of
hypnotherapy in the treatment of
severe refractory irritable-bowel
syndrome. Lancet 2: pp 1232 - 1233
45. Radnitz CL & Blanchard EB (1989)
A 1- and 2-year follow-up study of
bowel sound feedback as a treatment
of irritable bowel syndrome.
Biofeedback & Self Regulation 14(4):
pp 333 - 338
46. Goldenberg JZ, Brignall M, Hamilton
M, Beardsley J, Batson RD, Hawrelak
J et al (2019) . Biofeedback for
treatment of irritable bowel syndrome.
Cochrane Database of Systematic
Reviews. 2019(11) CD012530. doi:
47. Laird KT, Tanner-Smith EE, Russell
AC, Hollon SD & Walker LS (2017)
Comparative efficacy of psychological
therapies for improving mental health
and daily functioning in irritable
bowel syndrome: a systematic
review and meta-analysis. Clinical
Psychology Review 51: pp 142 – 152
48. Schumann D, Anhever D, Lauche R,
Dobos G, Langhorst J & Cramer H
(2016) Effect of yoga in the therapy of
irritable bowel syndrome: a systematic
review. Clinical Gastroenterology &
Hepatology 14(12): pp1720 - 1731
49. Ghandi F, Sadeghi A, Bakhtyari
M, Imani S, Abdi S & Banihashem
SS (2018) Comparing the efficacy
of mindfulness-based stress
reduction therapy with emotion
regulation treatment on quality
of life and symptoms of irritable
bowel syndrome. Iranian Journal of
Psychiatry 13(3): pp 175 – 183